Home/Filings/4/0001654954-17-004944
4//SEC Filing

NAVIDEA BIOPHARMACEUTICALS, INC. 4

Accession 0001654954-17-004944

CIK 0000810509operating

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:10 PM ET

Size

5.7 KB

Accession

0001654954-17-004944

Insider Transaction Report

Form 4
Period: 2017-05-17
Latkin Jed
Interim COO
Transactions
  • Award

    Common Stock, $.001 par value

    2017-05-17$0.47/sh+13,300$6,21113,300 total
  • Award

    Common Stock, $.001 par value

    2017-05-18$0.45/sh+3,900$1,75317,200 total

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000810509

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:10 PM ET
Size
5.7 KB